pharmaphorum18m
Novo Nordisk leaps on new obesity drug data
Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 ...
Officers at Upstate treated after exposure to unknown substance
MALONE — Union officials confirmed that on Wednesday multiple correction officers and staff were recently treated at a ...